Developing resistance-breaking insecticides at mosquito muscarinic acetylcholine receptors to reduce malaria transmission
Developing resistance-breaking insecticides at mosquito muscarinic acetylcholine receptors to reduce malaria transmission
批准号:
10471845
负责人:
Aaron Donald Gross
金额:
$15.08万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-20 至 2024-07-31
关键词:
AgonistAgricultureAgrochemicalsAnopheles gambiaeAtropineBiologicalBiological AvailabilityBiologyCentral Nervous SystemChemicalsChemistryCulicidaeDataDerivation procedureDevelopmentElectrophysiology (science)EvolutionG-Protein-Coupled ReceptorsGoalsHealthHumanInsect ControlInsectaInsecticide ResistanceInsecticidesInvestigationKnowledgeKnowledge acquisitionLeadLibrariesLigandsMalariaMammalsMarketingMidgutMissionMosquito ControlMosquito-borne infectious diseaseMuscarineMuscarinic Acetylcholine ReceptorMuscarinicsNational Institute of Allergy and Infectious DiseaseNeuronsNeurosciencesNutrientOralOutcomeOximesPathway interactionsPest ControlPharmacologic SubstancePharmacologyPhysiologicalPhysiological ProcessesPhysiologyPlayPopulationPublic HealthPyrazolesRecyclingResearchResistanceResistance developmentRoleScopolamineSeriesSystemTestingToxic effectToxicologyWorkabsorptionacetylcholine receptor agonistanalogantagonistcholinergicdietaryglobal healthimprovedinnovationmalaria transmissionnovelpharmacologicpreventprogramsreceptorsmall moleculesmall molecule librariestoxicantuptakevectorvector transmissionvector-borne pathogen
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Reducing vector populations will help decrease the global impact of mosquito-borne diseases. Over reliance on
insecticide classes repurposed from agriculture has culminated in widespread resistance, resulting in a critical
need to investigate physiological processes that can provide selective targets for insecticide development. Insect
muscarinic acetylcholine receptors (mAChRs) have been validated as an insecticide target, but no molecules
with this mode of action are currently used for pest control. The long-term goal of the proposed research is to
exploit pharmacological differences between insects and mammals to develop mAChR-selective insecticides to
be integrated into mosquito control programs. The overall objective of the proposed research is to investigate
the pharmacology and physiology of Anopheles gambiae mAChRs using chemical probes and novel nutrient
conjugates to enhance oral delivery of these toxicants. The central hypothesis of the proposed research is that
insect mAChR subtypes display unique pharmacology and play critical roles in the mosquito central nervous
system (CNS). The rationale for the proposed research is based on the global health burden that mosquitoes
impose, with a focus on the malarial vector Anopheles gambiae. Two specific aims will be performed to test the
central hypothesis. Specific Aim #1 will interrogate the pharmacology of An. gambiae mAChR subtypes using a
cholinergic chemical library with defined biological and pharmaceutical activity. Specific Aim #2 will focus on the
synthesis of a series of analogs of a lead molecule to probe the function of mosquito muscarinic receptor activity,
as well as absorption pathways for its dietary delivery. The proposed research is conceptually innovative as it is
a departure from the status quo by i) investigating the muscarinic system as an unexploited mode of action to
break insecticide resistance, and ii) leveraging midgut nutrient transporters to facilitate dietary uptake of pro-
insecticides. This project will provide significant advances to the fields of mosquito biology, as well as insecticide
toxicology and development.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/ps.7079
发表时间:
2022-11
期刊:
PEST MANAGEMENT SCIENCE
影响因子:
4.1
作者:
[Xie, Na, Gross, Aaron D.]
通讯作者:
Gross, Aaron D.
Developing resistance-breaking insecticides at mosquito muscarinic acetylcholine receptors to reduce malaria transmission
-
批准号:10218380
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2021
-
负责人:Aaron Donald Gross
-
依托单位:
海外基金